Astrazeneca Pharma India Ltd (ASTRAZEN) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 777011,
    "name": "Astrazeneca Phar",
    "stock_name": "Astrazeneca Phar",
    "full_name": "Astrazeneca Pharma India Ltd",
    "name_url": "stocks-analysis/astrazeneca-phar",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "8,489.25",
    "chg": -46.05,
    "chgp": "-0.54%",
    "dir": -1,
    "prev_price": "8,535.30",
    "mcapval": "21,555.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 506820,
    "symbol": "ASTRAZEN",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE203A01020",
    "curr_date": "May 08",
    "curr_time": "",
    "bse_nse_vol": "4.36 k",
    "exc_status": "Active",
    "traded_date": "May 08, 2026",
    "traded_date_str": "2026 05 08",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/astrazeneca-phar-777011-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Astrazeneca Pharma India Ltd Sees Mixed Technical Signals Amid Mild Momentum Shift",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/astrazeneca-pharma-india-ltd-sees-mixed-technical-signals-amid-mild-momentum-shift-3980765",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AstrazenecaPhar_technicaldot_3980765.png",
        "date": "2026-05-08 08:03:49",
        "description": "Astrazeneca Pharma India Ltd has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Despite a recent upgrade from Hold to Sell by MarketsMOJO, the stock’s price action and technical indicators suggest a cautiously evolving outlook for this small-cap pharmaceutical player."
      },
      {
        "title": "Astrazeneca Pharma India Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/astrazeneca-pharma-india-ltd-is-rated-sell-3977648",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AstrazenecaPhar_mojoScore_3977648.png",
        "date": "2026-05-06 10:10:03",
        "description": "Astrazeneca Pharma India Ltd is rated Sell by MarketsMOJO. This rating was last updated on 02 Jan 2026. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 06 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "Astrazeneca Pharma India Ltd Sees Mixed Technical Signals Amid Price Momentum Shift",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/astrazeneca-pharma-india-ltd-sees-mixed-technical-signals-amid-price-momentum-shift-3973648",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AstrazenecaPhar_technicaldot_3973648.png",
        "date": "2026-05-04 08:01:42",
        "description": "Astrazeneca Pharma India Ltd has experienced a notable shift in its technical momentum, moving from a bearish to a mildly bearish trend as of early 2026. Despite a recent downgrade in its Mojo Grade from Hold to Sell, the stock’s mixed technical signals across key indicators such as MACD, RSI, Bollinger Bands, and moving averages suggest a complex outlook for investors navigating the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Astrazeneca Pharma India Ltd Faces Bearish Momentum Amid Technical Downgrade",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/astrazeneca-pharma-india-ltd-faces-bearish-momentum-amid-technical-downgrade-3967484",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/AstrazenecaPhar_technicaldot_3967484.png",
        "date": "2026-04-29 08:02:41",
        "description": "Astrazeneca Pharma India Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a more pronounced bearish trend. Despite some bullish signals on longer-term indicators, the overall technical landscape suggests caution for investors as the stock contends with downward pressure amid mixed momentum indicators and a recent downgrade in its Mojo Grade to Sell."
      },
      {
        "title": "Astrazeneca Pharma India Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/astrazeneca-pharma-india-ltd-is-rated-sell-3962181",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/AstrazenecaPhar_mojoScore_3962181.png",
        "date": "2026-04-25 10:10:14",
        "description": "Astrazeneca Pharma India Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 02 Jan 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 April 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Astrazeneca Pharma India Ltd Sees Mixed Technical Signals Amid Price Momentum Shift",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/astrazeneca-pharma-india-ltd-sees-mixed-technical-signals-amid-price-momentum-shift-3946666",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/AstrazenecaPhar_technicaldot_3946666.png",
        "date": "2026-04-15 08:03:27",
        "description": "Astrazeneca Pharma India Ltd has experienced a notable shift in price momentum, reflected in a 5.21% gain on 15 Apr 2026, as technical indicators reveal a complex picture of mildly bearish to bullish signals across weekly and monthly timeframes. Despite a recent downgrade from Hold to Sell by MarketsMOJO, the stock’s long-term returns remain robust, outperforming the Sensex over multiple periods."
      },
      {
        "title": "Astrazeneca Pharma India Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/astrazeneca-pharma-india-ltd-is-rated-sell-3945626",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/AstrazenecaPhar_mojoScore_3945626.png",
        "date": "2026-04-14 10:10:14",
        "description": "Astrazeneca Pharma India Ltd is rated Sell by MarketsMOJO. This rating was last updated on 02 Jan 2026. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 14 April 2026, providing investors with the latest insights into the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Astrazeneca Pharma India Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/astrazeneca-pharma-india-ltd-is-rated-sell-3932671",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/AstrazenecaPhar_mojoScore_3932671.png",
        "date": "2026-04-03 10:10:02",
        "description": "Astrazeneca Pharma India Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 02 Jan 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 03 April 2026, providing investors with an up-to-date view of the company’s performance and outlook."
      },
      {
        "title": "Astrazeneca Pharma India Ltd Hits Intraday Low Amid Price Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/astrazeneca-pharma-india-ltd-hits-intraday-low-amid-price-pressure-3920287",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AstrazenecaPhar_priceRelatedfactors_3920287.png",
        "date": "2026-03-27 15:41:06",
        "description": "Astrazeneca Pharma India Ltd experienced a significant intraday decline on 27 Mar 2026, touching a low of Rs 7,825, down 7.02% from the previous close. The stock underperformed its sector and broader market indices amid widespread selling pressure and bearish technical signals."
      }
    ],
    "total": 363,
    "sid": "777011",
    "stock_news_url": "https://www.marketsmojo.com/news/astrazeneca-pharma-india-777011"
  },
  "announcements": [
    {
      "caption": "Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation 2015",
      "datetime": "10-Apr-2026",
      "details": "Please find the enclosed intimation of the Company as per the captioned subject for your reference.",
      "source": "BSE"
    },
    {
      "caption": "Shareholder Meeting / Postal Ballot-Notice of Postal Ballot",
      "datetime": "10-Apr-2026",
      "details": "Please find the enclosed intimation of the Company as per the captioned subject for your reference.",
      "source": "BSE"
    },
    {
      "caption": "Shareholder Meeting / Postal Ballot-Scrutinizers Report",
      "datetime": "31-Mar-2026",
      "details": "Please find the enclosed intimation of the Company as per the captioned subject for your reference.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Astrazeneca Pharma India Ltd has declared <strong>1600%</strong> dividend, ex-date: 18 Jul 25",
          "dt": "2025-07-18",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Astrazeneca Pharma India Ltd has announced <strong>2:10</strong> stock split, ex-date: 15 Jun 06",
          "dt": "2006-06-15",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Astrazeneca Pharma India Ltd Sees Mixed Technical Signals Amid Mild Momentum Shift

2026-05-08 08:03:49

Astrazeneca Pharma India Ltd has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Despite a recent upgrade from Hold to Sell by MarketsMOJO, the stock’s price action and technical indicators suggest a cautiously evolving outlook for this small-cap pharmaceutical player.

Read full news article

Astrazeneca Pharma India Ltd is Rated Sell

2026-05-06 10:10:03

Astrazeneca Pharma India Ltd is rated Sell by MarketsMOJO. This rating was last updated on 02 Jan 2026. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 06 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Read full news article

Astrazeneca Pharma India Ltd Sees Mixed Technical Signals Amid Price Momentum Shift

2026-05-04 08:01:42

Astrazeneca Pharma India Ltd has experienced a notable shift in its technical momentum, moving from a bearish to a mildly bearish trend as of early 2026. Despite a recent downgrade in its Mojo Grade from Hold to Sell, the stock’s mixed technical signals across key indicators such as MACD, RSI, Bollinger Bands, and moving averages suggest a complex outlook for investors navigating the Pharmaceuticals & Biotechnology sector.

Read full news article

Astrazeneca Pharma India Ltd Faces Bearish Momentum Amid Technical Downgrade

2026-04-29 08:02:41

Astrazeneca Pharma India Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a more pronounced bearish trend. Despite some bullish signals on longer-term indicators, the overall technical landscape suggests caution for investors as the stock contends with downward pressure amid mixed momentum indicators and a recent downgrade in its Mojo Grade to Sell.

Read full news article

Astrazeneca Pharma India Ltd is Rated Sell

2026-04-25 10:10:14

Astrazeneca Pharma India Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 02 Jan 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 April 2026, providing investors with the latest insights into its performance and outlook.

Read full news article

Astrazeneca Pharma India Ltd Sees Mixed Technical Signals Amid Price Momentum Shift

2026-04-15 08:03:27

Astrazeneca Pharma India Ltd has experienced a notable shift in price momentum, reflected in a 5.21% gain on 15 Apr 2026, as technical indicators reveal a complex picture of mildly bearish to bullish signals across weekly and monthly timeframes. Despite a recent downgrade from Hold to Sell by MarketsMOJO, the stock’s long-term returns remain robust, outperforming the Sensex over multiple periods.

Read full news article

Astrazeneca Pharma India Ltd is Rated Sell

2026-04-14 10:10:14

Astrazeneca Pharma India Ltd is rated Sell by MarketsMOJO. This rating was last updated on 02 Jan 2026. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 14 April 2026, providing investors with the latest insights into the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Astrazeneca Pharma India Ltd is Rated Sell

2026-04-03 10:10:02

Astrazeneca Pharma India Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 02 Jan 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 03 April 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Read full news article

Astrazeneca Pharma India Ltd Hits Intraday Low Amid Price Pressure

2026-03-27 15:41:06

Astrazeneca Pharma India Ltd experienced a significant intraday decline on 27 Mar 2026, touching a low of Rs 7,825, down 7.02% from the previous close. The stock underperformed its sector and broader market indices amid widespread selling pressure and bearish technical signals.

Read full news article

View All News